Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 19 citing Knopp: Efficacy and safety of atorvastatin in the prevention of cardiovascular end points.... (0.10 sec) 

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in …

- Free from Publisher
RH Knopp - Diabetes Care, 2006 - Am Diabetes Assoc
We mention in our article the high rates of treatment “drop in” and “drop
out” and the potential impact on the primary end point (mostly due to changing
guidelines and study design changes). While Gazi and Mikhailidis correctly ...
Cited by 100 - Related articles - BL Direct - All 8 versions

A clinical screening tool identifies autoimmune diabetes in adults

- diabetesjournals.org
S Fourlanos, C Perry, MS Stein, J Stankovich … - Diabetes Care, 2006 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Subjects with LADA (n = 102, GAD antibody [GADA]+)
and type 2 diabetes (n = 111, GADA−) (aged 30–75 years) were interviewed
retrospectively. The clinical features documented were age of onset, acute ...
Cited by 38 - Related articles - BL Direct - All 6 versions

[R-(R* R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino) …


B Roth - US Patent RE40,667, 2009 - Google Patents
Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8. Page 9. Page 10.
Page 11. Page 12. Page 13. Page 14. Page 15. Page 16. Page 17.
Cited by 13 - Related articles - All 4 versions

Treatment of dyslipidemia in patients with type 2 diabetes: overview and meta-analysis of …


I Tkáč - Diabetes Research and Clinical Practice, 2007 - Elsevier
We performed a meta-analysis of six secondary prevention trials with statins.
Overall, a significant reduction in major coronary events (death from coronary
artery disease or non-fatal myocardial infarction) by 22% was observed in ...
Cited by 5 - Related articles - All 5 versions

Reassessment of cardiovascular risk in diabetes


JR Jaffe, SS Nag, PB Landsman, CM … - Current opinion in lipidology, 2006 - journals.lww.com
Purpose of review To review recent trials and reassess cardiovascular risk in
people with diabetes. Recent findings Recent clinical trials have tended to
focus on lower-risk participants with diabetes who have had event rates ...
Cited by 5 - Related articles - BL Direct - All 4 versions

Atorvastatin in prevention of stroke and transient ischaemic attack


P Amarenco - Expert Opin. Pharmacother., 2007 - informahealthcare.com
Besides blood pressure-lowering drugs and, in certain circumstances,
antithrombotic agents, statins are among the most effective drugs in reducing
the risk of stroke in populations of patients at high vascular risk, as ...
Cited by 4 - Related articles - BL Direct - All 6 versions

Hyperlipidaemia and cardiovascular disease

- nursing2008.com
LH Kuller - Current opinion in lipidology, 2000 - journals.lww.com
Stamler et al. [4••] recently evaluated younger men (aged 18-39 years) in
three cohorts. Mean serum cholesterol levels varied between 190 and 205 mg/dl,
and none of the individuals studied were diabetic or had prior history of ...
Cited by 3 - Related articles - BL Direct - All 11 versions

LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach?

- utas.edu.au [PDF] 
RW Nesto - Clinical Diabetes, 2008 - Am Diabetes Assoc
Managing the high risk for cardiovascular morbidity and mortality in diabetic
patients is a challenge for practicing clinicians. Reducing the burden of
cardiovascular disease in diabetes should begin with assessment and ...
Cited by 3 - Related articles - BL Direct - All 7 versions

Do People With Diabetes Need Statins?


JR White Jr - The Diabetes Educator, 2008 - tde.sagepub.com
The prevalence of type 2 diabetes mellitus continues to increase rapidly.
Persons with diabetes face a 2-fold greater absolute risk of cardiovascular
disease (CVD) than those without diabetes. Many diabetic patients die ...
Cited by 1 - Related articles - All 2 versions

Prevention and noninvasive management of coronary atherosclerosis in patients with …


MG Bourassa, C Berry - Current Atherosclerosis Reports, 2008 - Springer
Diabetes mellitus (DM) is a worldwide epidemic. Its prevalence is rapidly
increasing in both developing and developed countries. Coronary heart disease
(CHD) is highly prevalent and is the major cause of morbidity and mortality ...
Cited by 1 - Related articles - BL Direct - All 2 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google